Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE (Open Access)

Perceptions, experiences and concerns with sexually transmitted infections among current and former PrEP users: a longitudinal qualitative study of gay, bisexual and queer men in Canada

Emerich Daroya https://orcid.org/0000-0003-2024-4240 A B , Alex Wells C , Mark Gaspar A , Jad Sinno A , Mark Hull D , Nathan J. Lachowsky C , Darrell H. S. Tan A E and Daniel Grace https://orcid.org/0000-0002-9032-3959 A *
+ Author Affiliations
- Author Affiliations

A Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

B Department of Politics, Media and Philosophy, La Trobe University, Melbourne, Vic, Australia.

C School of Public Health and Social Policy, University of Victoria, Victoria, BC, Canada.

D British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.

E St. Michael’s Hospital, Toronto, ON, Canada.

* Correspondence to: daniel.grace@utoronto.ca

Handling Editor: Benjamin Bavinton

Sexual Health 21, SH23195 https://doi.org/10.1071/SH23195
Submitted: 6 December 2023  Accepted: 22 October 2024  Published: 12 November 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

Abstract

Background

Pre-exposure prophylaxis (PrEP) use has been attributed to heightened rates of sexually transmitted infections (STIs), ostensibly due to increased condomless anal sex (CAS) and greater frequency of STI testing. Few qualitative studies have assessed how gay, bisexual and queer men (GBQM) who use PrEP perceive STIs and how these attitudes have evolved post-PrEP uptake. We investigated the perspectives of current and former PrEP users on STIs.

Methods

Annual, in-depth longitudinal interviews were conducted with 38 current and former PrEP users in Ontario (n = 18) and British Columbia (n = 20), Canada, as part of a mixed-methods implementation science study (2020–2022). Over 3 years, 109 interviews were conducted. Data analysis included reflexive thematic coding and longitudinal recurrent cross-sectional analysis using NVivo 12.

Results

Four STI-related themes emerged: (1) lack of STI-related concerns due to treatment and prevention optimism, (2) stigma-related concerns, (3) perceived risk among other PrEP users due to increased CAS, and (4) inconsistent testing concerns among non-PrEP users. Over time, some STI-related anxieties decreased with increased knowledge and reduced stigma. However, concerns persisted for other participants due to perceived risky sexual behaviours among other PrEP users and non-PrEP users. Both current and former PrEP users who expressed STI-related apprehensions consistently indicated adopting risk-reduction strategies, including condom use and having fewer sexual partners throughout the study.

Conclusions

Findings show how varied STI perceptions and experiences among current and former PrEP users shaped sexual decision-making over time. Providers, public health experts, and policymakers should develop a more comprehensive strategy to address STI concerns among GBQM.

Keywords: Canada, gay, bisexual, and queer men, GBQM, HIV, longitudinal, MSM, pre-exposure prophylaxis, PrEP, qualitative, risk perceptions, sexual behaviour, sexual health, sexually transmitted infections, stigma, STIs.

Introduction

Pre-exposure prophylaxis (PrEP) is one important strategy for preventing HIV transmission among gay, bisexual and queer men (GBQM), who represent the highest number of HIV diagnoses in Canada.1 PrEP availability has sparked debate among healthcare providers, researchers, and community members about its impact on sexual behaviours, particularly concerning the heightened incidence of condomless anal sex (CAS)2,3 and associated sexually transmitted infections (STIs).46 However, evidence about increased CAS when using PrEP has been inconclusive.7,8 There was similar uncertainty regarding STI incidence rates among GBQM PrEP users. In a meta-analysis of PrEP trials and cohort studies, researchers found varying STI rates – some reported high STI rates following uptake, while others showed stable or decreased incidence.6 For Grov et al., these results should be approached carefully to determine whether higher STI rates can be attributed to increased CAS or the more frequent STI testing as part of PrEP care.2

GBQM PrEP users have been reported to appreciate the increased frequency of STI testing.2 Although research has explored the association between PrEP use and STI incidence, only a few qualitative studies have examined how GBQM PrEP users perceive STIs and how they enter into sexual decision-making.911 These studies established that GBQM PrEP users were less concerned about STIs than HIV, as they perceived HIV as more severe due to its chronic nature.912 However, some expressed worry about particular STIs, including resistant gonorrhoea and hepatitis C.10 Researchers also concluded that some PrEP users employed strategies to reduce their STI susceptibility, including condom use and avoiding certain sexual activities (e.g. no anal sex when they did not trust their partners).10,12 Despite these findings, how attitudes toward STIs, including STI-related stigma, have evolved for GBQM PrEP users is unclear.

This study had two interrelated objectives. First, we aimed to provide insights into how STIs were perceived and experienced by GBQM PrEP users. Second, we investigated how STI perceptions and experiences informed PrEP users’ sexual decision-making over time by analysing accounts from a longitudinal qualitative study in Ontario and British Columbia (BC), Canada.

Methods

Design and setting

Data were derived from the PrEP Implementation Project (PRIMP), a mixed-methods implementation science study. The study aimed to understand how to better deliver PrEP to GBQM in Canada’s two largest provinces with varying PrEP access. In BC, PrEP is free for most residents, including Canadian citizens, permanent residents, refugees, and Indigenous people, who have access to the province’s Medical Services Plan.13 Meanwhile, in Ontario, PrEP is free for specific groups (e.g. <25, 65+ years of age) and publicly funded but with co-payments for others. PrEP in Ontario costs around CAD250/month, with most insurance plans covering between 50 and 100% of out-of-pocket expenses.14 The PRIMP study involved in-depth longitudinal interviews with current and former PrEP and non-PrEP users to discuss their experiences and interest in PrEP. This study involved human participants and was approved by the University of Toronto Research Ethics Board (Ref. 11252), Unity Health Toronto Research Ethics Board (Ref. 1694), University of British Columbia Research Ethics Board, University of Victoria Research Ethics Board, and Island Health Research Ethics Board (Harmonised, Ref. H18-01525). Details of the study have been reported elsewhere.1518

Recruitment and participants

Participants were recruited from participating clinics and community partners. Eligible participants had to be at least 19 years old, HIV-negative, sexually active, and identify as GBQM. To ensure consistency across study sites, we recruited participants aged 19 years and over to align with the minimum age for accessing healthcare services in both provinces. Although Ontario allows minors aged 14 years and older to consent to care, BC requires patients to be 19 years of age.19 Individuals were eligible to participate regardless of PrEP experience (i.e. never used PrEP, former PrEP user, or current PrEP user). A recruitment website and poster were shared with potential participants over email and social media. These recruitment tools linked to an eligibility screener used to increase the diversity of participants, including GBQM with diverse PrEP use histories, balanced representation of racial and ethnic backgrounds, a range of ages, and inclusion of gender-diverse participants. All participants gave informed consent to participate in the study. A total of 38 participants who were current or former PrEP users were recruited in Ontario (n = 18) and BC (n = 20).

The first round of interviews in Ontario was conducted in March–July 2020 (T1), the second round in June–September 2021 (T2), and the third round in March–May 2022 (T3). Among the 18 participants, 15 completed three interviews, 2 completed two, and 1 was interviewed once. In BC, the first round of interviews was conducted in October–December 2020 (T1), the second round in September–November 2021 (T2), and the third round in November–December 2022 (T3). Nineteen participants completed three interviews, and one was interviewed twice. In both study sites, 34 individuals completed all three interviews.

Data collection and analysis

An interview guide was developed in consultation with a community advisory board comprising of partners from GBQM health organisations. Across the three time points, participants were asked questions about STI history, testing, and experience. All interviews were conducted online due to COVID-19 public health restrictions. Interviews lasted 30–90 min, were audio recorded, and transcribed verbatim. Participants received a CAD30 honorarium for the first interview, CAD50 for the second, and CAD70 for the third.

A total of 109 interviews were conducted. Data analysis included reflexive thematic coding and longitudinal recurrent cross-sectional analysis using NVivo Version 12 (QSR International; http://www.qsrinternational.com/nvivo). After each round of interviews, a reflexive thematic analysis was performed.20,21 After the three rounds of interviews, a longitudinal analysis was conducted. Building on previous qualitative longitudinal research, each theme was organised chronologically, and differences and similarities between each time point were looked for.22,23 Longitudinal analysis focused on tracing individual trajectories over time. It was then shared with the entire team for feedback. Pseudonyms are used throughout to trace narratives across the time points.

Results

Participant sociodemographic characteristics are shown in Table 1. Thirty participants described using PrEP, nine were former PrEP users, and two never took PrEP at baseline (though these two subsequently reported starting PrEP in 2021). Nine participants stopped PrEP use in 2020, eight in 2021, and 10 in 2022. Two participants completely discontinued using PrEP before the initial interviews in 2020. Reasons for PrEP discontinuation included decreased sexual activities (particularly during the COVID-19 pandemic16), relationship changes, side effects, and loss of health insurance, but they were not due to STI-related concerns.

Table 1.Participant sociodemographic characteristics at baseline.

 Ontario (n = 18) n (%)British Columbia (n = 20) n (%)Total (n = 38) n (%)
Age range (years)
 19–298 (44)4 (20)12 (35)
 30–397 (39)9 (45)16 (37)
 40–493 (17)2 (10)5 (14)
 50+0 (0)5 (25)5 (14)
Ethno-racial background
 Black3 (16)2 (10)5 (13)
 East/Southeast Asian4 (22)4 (20)8 (22)
 Indigenous/Métis0 (0)3 (15)3 (8)
 Latin American1 (6)2 (10)3 (8)
 Middle Eastern2 (11)1 (5)3 (8)
 Mixed race/ethnicity0 (0)1 (5)1 (3)
 South Asian1 (6)0 (0)1 (3)
 White7 (39)7 (35)14 (35)
Gender identity
 Cisgender17 (94)20 (100)37 (97)
 Transgender1 (6)01 (3)
Sexual identity
 Gay17 (94)19 (95)36 (94)
 Bisexual/queer1 (6)0 (0)1 (3)
 Two-spirit0 (0)1 (5)1 (3)
PrEP use status
 Taking PrEP13 (72)17 (85)30 (80)
 Former PrEP users5 (22)4 (10)9 (16)
 Have never taken PrEPA1 (6)1 (5)2 (4)
A These participants have taken PrEP at a subsequent time point (2021).

Data analysis revealed four key themes regarding STI concerns: (1) lack of STI-related concerns due to treatment and prevention optimism, (2) stigma-related apprehensions, (3) perceived risk among other PrEP users due to increased CAS, and (4) perceived risk among non-PrEP users due to inconsistent testing. Although most participants expressed no STI-related concerns, some individuals mentioned apprehensions linked to stigma and perceived risk among PrEP users and non-PrEP users. Arguably, assumptions about other men’s STI status can inadvertently contribute to negative attitudes about GBQM as STI carriers. Participants’ STI perceptions and experiences varied over time. Although minimal concern remained unchanged, some anxieties decreased over time as participants gained more knowledge about treatments and experienced less stigma. However, other participants continued to have apprehensions due to perceived risky sexual practices among PrEP and non-PrEP users. Both current and former PrEP users who expressed STI-related concerns consistently indicated adopting risk-reduction strategies, including condom use and having fewer sexual partners throughout the study.

Lack of STI-related concerns due to treatment and prevention optimism

Throughout the interview time points, almost all participants perceived HIV as more severe because of its permanency, whereas STIs were considered minor inconveniences due to easy access to medications and frequent testing. For example, Omar said, ‘I wasn’t afraid of the other STIs because there’s treatments, like HIV is one that you’re kind of living with for the rest of your life’ (age 30s, BC, current user at T1). Despite some participants reporting an increase in CAS due to PrEP use and acknowledging heightened STI risks, many of them expressed a lack of STI-related concerns. As Rishi shared, ‘I stopped using condoms [and] took more risks with STIs […], but I know that they’re treatable’ (age 40s, Ontario, current user at T1). For these men, factors such as their partner’s HIV status or PrEP use did not significantly impact their apprehension about contracting STIs. For example, Zayn stated, ‘Because of my PrEP use, I don’t ask people about their HIV status’ (age 20s, Ontario, current user at T2).

Availability of medications in controlling and managing STIs

For many participants, STIs were perceived as less concerning because of the availability of medications to treat and control them. Although the same could be said for HIV, most understood HIV as a chronic infection, whereas STIs were easier to treat. These views remained consistent, and participants emphasised their lack of STI-related concerns linked to treatment and prevention optimism. For example, Ben, a participant who stopped PrEP use before his first interview, expressed optimism about STI treatments, saying, ‘There’s a treatment for everything else but HIV’ (age 30s, BC, former user at T1). Ben reported contracting gonorrhoea and chlamydia previously, but when asked about condom use during sex, Ben responded, ‘Usually, I’m not’ (T1). Fast forward to 2022, Ben, having resumed PrEP use, echoed his earlier sentiments, indicating a lack of concern about STIs, stating, ‘It’s not really something I think about a lot […]. I guess, in general, I know what the risk factors are, and I know about the tools I can access if I need them’ (current user at T3).

Similarly, Jack, who reported acquiring gonorrhoea and chlamydia in 2020, said he was not concerned about STIs because ‘most STIs are treatable or controllable’ (age 30s, BC, current user at T1). Later, Jack said that ‘nothing bothered’ him about STIs because he was aware of the ‘tools’ to access ‘PrEP, medications, and vaccinations’ (current user at T3). Jack further discussed that the availability of daily doxycycline pre-exposure prophylaxis (Doxy-PrEP), which involves taking antibiotics to prevent bacterial STIs,24 had alleviated his concerns: ‘There is your daily doxy, [which] takes care of your syphilis and chlamydia’ (T3). Throughout his interviews, Jack consistently said he did not use condoms when engaging in sex.

Frequent testing lowers STI concerns

Many PrEP users said they were not worried about STIs due to frequent testing associated with PrEP care. Over time, these views remained unchanged. One participant who reported acquiring syphilis in 2020 said he was less anxious about STIs because he knew ‘they [were] treatable’ (Rishi, age 40s, Ontario, current user at T1). In 2022, Rishi noted contracting ‘one [STI] a year,’ which he further described as ‘inevitable if you’re having sex’ (current user at T3). However, Rishi clarified that he was not worried about being diagnosed with STIs due to frequent testing as part of PrEP care: ‘The good thing [about] PrEP [is that] at least people now get tested, so I get a call after that happens, so that part’s good’ (T3). While expressing optimism about testing, Rishi mentioned throughout his interviews that he continues to use condoms sometimes because, as he described, acquiring STIs ‘always freaks me out’ (T3). In 2020, Rishi said, ‘I’m still using condoms’, except when engaging in sex with partners he trusted: ‘So [with] someone I trusted, I kind of would not use a condom’ (T1). During his final interview, Rishi described his condom use as ‘sometimes used […] and sometimes no’ (T3).

In 2020, Tarik, who reported never acquiring STIs, shared ‘[STIs] don’t concern me. That’s why I always do my test every 3 months’ (age 20s, Ontario, current user T1). Later, Tarik commented that managing STIs was only a matter of ‘getting checked every 3 months [and] […] [taking] medication’ and reported using ‘condoms less’ (current user at T3).

Stigma-related apprehensions

Acquiring STIs was concerning for some participants because of self-stigmatisation and the perceived stigma associated with these conditions.25 Participants raised apprehensions regarding feeling ‘unclean’ and ‘embarrassed’ when contracting STIs. Additionally, they expressed worries about being stigmatised when disclosing an STI diagnosis to sexual partners. Over time, the trajectories of STI-related stigma concerns evolved as they better understood treatment options. For example, Jamal described experiencing self-stigma after his first gonorrhoea and chlamydia infections: ‘I felt self-degrading, and like, I’m not clean’ (age 20s, Ontario, current user at T1). However, upon receiving medications, Jamal realised that ‘it was such a basic treatment’ (T1). Later, Jamal did not discuss how STIs have generated feelings of shame. Instead, he articulated how he ‘[knew] how other STIs work, especially the bacterial ones’ (current user at T2). For Jamal, receiving medications for STIs and obtaining regular testing as part of PrEP care appeared to have helped in destigmatising STIs.

Harry also described experiencing self-stigmatisation and perceived stigma. He reported acquiring chlamydia and felt ‘really embarrassed’ about ‘having to explain to previous partners’ (age 30s, BC, current user at T1). During his 2022 interview, however, Harry did not discuss any STI-related stigma. Instead, Harry reported discontinuing PrEP because he ‘wasn’t having anonymous anal sex’ and perceived himself as low risk due to primarily engaging in oral sex (former user at T3).

Perceived risk among other PrEP users due to increased CAS

Some men expressed concerns about their risk of acquiring STIs due to perceived increased CAS among other PrEP users, which persisted throughout the study. Although Damien did not voice any apprehensions about STIs because ‘we can still treat them’, he described some anxiety about other PrEP users engaging in CAS (age 40s, BC, current user at T1). In 2021, Damien explained how other PrEP users ‘view PrEP as a panacea for all things’ (current user at T2). He also discussed how other PrEP users ‘are more willing to buy into the freedom that gives them to have sex without a condom’ (T2).

Similarly, Tyler discussed how ‘other STDs […] aren’t getting enough attention’ because he believed that ‘the focus was always so much on HIV’ (age 20s, Ontario, former user at T3). He continued, ‘The fact that condoms prevent other STDs has […] gone out of the window’ (T3). During Tyler’s first interview, he said that engaging in CAS was not a ‘regular practice’ he engaged in because of his previous experience with syphilis: ‘I know there’s other STIs that you can get’ (current user at T1). Later, however, Tyler discussed that he was ‘not a fan of [condoms]’ but acknowledged their utility (‘very much useful’) (former user at T3). By contrast, Damien described wearing condoms ‘most of the time’ (current user at T1, T3).

Perceived risk among non-PrEP users due to inconsistent testing

Some participants expressed concerns about acquiring STIs from individuals they believed were not undergoing regular STI testing, particularly non-PrEP users unaware of their HIV status. Some participants consistently expressed these views across the three time points. Although Aiden explained his low fears about STIs, he worried about other people ‘not getting tested […] [especially people] who don’t already know their status’ (age 30s, Ontario, current user at T1). He continued,

If you’re on PrEP, you’re getting tested regularly because it’s simply part of the process. But for people who are not, it’s not uncommon for me to hear stories of people not getting tested. (T1)

Aiden’s concerns regarding STIs did not change in 2022, and he discussed that he was ‘using condoms’ when ‘having sex with a new partner’ to avoid STI acquisition (current user at T3).

Although some participants’ STI-related concerns linked to inconsistent testing among non-PrEP users remained constant, others expressed anxieties only once during the 3-year study period. For example, Jack consistently expressed optimism about treatment and prevention throughout the study (T1 and T3). However, in 2021, he noted that the COVID-19 pandemic created barriers to testing, which may have hindered some GBQM from getting tested, potentially impacting the spread of STIs. As Jack said, ‘People can’t get their testing as regularly done, so you probably see pockets of that spiking and spreading’ (age 30s, BC, current user at T2).

Discussion

The perceptions and experiences of STIs among current and former PrEP users in this study varied, influencing their sexual decision-making, particularly concerning condom use. Although no substantial provincial differences were found, most participants viewed STIs as temporary inconveniences because they were preventable and treatable with medication, suggesting STI treatment and prevention optimism.26 Study participants also emphasised the role of frequent testing, previously identified as a health benefit of PrEP,2 in the early detection of STIs. This lack of STI-related concerns has informed, to some extent, the decision among some study participants to forgo condoms when engaging in sexual activities, as observed in prior studies.9,10

Several participants expressed STI-related concerns, including the stigmatisation of STIs. They reported feeling ‘unclean’ when acquiring STIs, suggesting that being diagnosed with an STI could still evoke self-disgust and distress.27 Arguably, such responses inadvertently reinforce negative attitudes towards STIs and those affected by them.27,28 Other participants discussed feeling anxious about disclosing STIs to sexual partners. Due to concerns about STI-related stigma, some men mitigated their STI susceptibility by having fewer trusted partners and using condoms most or all the time. These risk mitigation strategies are consistent with previous research among PrEP users.10,12 Importantly, other participants’ internalised stigma dissipated with greater knowledge about STI treatment and prevention. These findings have several implications. First, an STI diagnosis can still generate shame and embarrassment among PrEP users. Second, stigma reduction programs and approaches must include discussions about STIs to assure GBQM who receive a diagnosis that they are not ‘unclean’.27 Third, it is crucial to enhance education on STI treatment and prevention to alleviate STI-related stigmatisation.

A few PrEP users made value judgments about other PrEP users who engage in sex without condoms, labelling them ‘reckless’ for increasing the risk of acquiring and transmitting STIs. Consequently, these men unintentionally contribute to the perception of some PrEP users as ‘bad PrEP users’ for having multiple sexual partners without using condoms, reinforcing prevailing discourses of ‘Truvada whores’ and inadvertently reproducing PrEP-related stigmatisation.29 Certain participants also voiced concerns about non-PrEP users perceived to undergo less frequent sexual health testing. By assuming how often non-PrEP users get tested, these participants blame them as carriers of STIs and portray PrEP users as responsible individuals actively prioritising their sexual health.30 Some participants who viewed other PrEP users and non-PrEP users as ‘risky’ for engaging in sex without condoms or undertaking infrequent sexual health testing reported consistent use of condoms, especially with new sexual partners.

These findings suggest that some PrEP users use condoms as a complementary method for STI prevention. Although this is the case for some, it is crucial for clinicians and public health professionals to cultivate a supportive and non-judgemental environment toward individuals who choose not to use condoms. It is also essential to emphasise the importance of routine testing for all GBQM regardless of HIV serostatus or PrEP use.

Our study is limited by focusing on GBQM living in or close to major urban centres in Ontario and BC. More research is needed on the perception and experiences of STIs among GBQM residing in smaller cities and rural settings. It is also noteworthy that a substantial majority of participants from BC were recruited through a sexual health clinic, where they were actively seeking PrEP services. Consequently, it is vital to acknowledge the selection bias resulting from this recruitment approach. This study focused on GBQM aged 19 years and older who use/have used PrEP. Future research is needed with younger PrEP users, including those aged 16 years and older, to understand how needs and usage patterns may change for this younger demographic.

Additionally, one participant mentioned Doxy-PrEP, which is not currently authorised by Health Canada and is only available through trials and off-label use.24 Further research should be conducted to help fill knowledge gaps and provide more robust evidence for using STI biomedical prevention. To our knowledge, this study represents the first longitudinal qualitative study to explore the perceptions and experiences of STIs among GBQM currently taking or have taken PrEP in Canada. As such, we were able to trace how the advent of PrEP and other preventive medications entered GBQM’s sexual decision-making and impacted STI considerations.

Conclusion

Our findings highlight how varied STI perceptions and experiences among current and former PrEP users shaped sexual decision-making over time. Although PrEP effectively reduces the risk of HIV acquisition, it poses challenges for STI prevention. Providers, public health experts, and policymakers should support the implementation of evidence-based biomedical prevention among GBQM. These could include retaining individuals who meet clinical criteria in PrEP care, promoting routine HIV and STI testing for all GBQM, providing free vaccinations for viral STIs (i.e. hepatitis B and human papillomavirus), and introducing doxycycline as pre-exposure or post-exposure prophylaxis to prevent bacterial STI transmission as complementary methods.

Data availability

The full qualitative transcripts supporting this study cannot be publicly shared due to ethical or privacy reasons.

Conflicts of interest

DHST’s institution has received support from Abbott and Gilead for investigator-initiated research grants and from Glaxo Smith Kline for industry-sponsored clinical trials. MH’s institution received support from Gilead for investigator-initiated research grants. The other authors have no conflicts of interest to declare.

Declaration of funding

This work was supported by a grant from the Canadian Institutes of Health Research (#CTW 155346).

Acknowledgements

The authors wish to thank the research participants, PRIMP Community Advisory Board, Karla Fisher, and Saira Mohammed.

References

Public Health Agency of Canada. Estimates of HIV incidence, prevalence, and Canada’s progress on meeting the 90-90-90 HIV Targets, 2020. Ottawa: Public Health Agency of Canada; 2020.

Grov C, Westmoreland DA, D’Angelo AB, et al. How has HIV pre-exposure prophylaxis (PrEP) changed sex? A review of research in a new era of bio-behavioral HIV prevention. J Sex Res 2021; 58(7): 891-913.
| Crossref | Google Scholar | PubMed |

Newcomb ME, Moran K, Feinstein BA, et al. Pre-exposure prophylaxis (PrEP) use and condomless anal sex: evidence of risk compensation in a cohort of young men who have sex with men. J Acquir Immune Defic Syndr 2018; 77(4): 358-364.
| Crossref | Google Scholar | PubMed |

Kumar S, Haderxhanaj LT, Spicknall IH. Reviewing PrEP’s effect on STI incidence among men who have sex with men—balancing increased STI Screening and potential behavioral sexual risk compensation. AIDS Behav 2021; 25(6): 1810-1818.
| Crossref | Google Scholar | PubMed |

Ramchandani MS, Golden MR. Confronting rising STIs in the era of PrEP and treatment as prevention. Curr HIV/AIDS Rep 2019; 16(3): 244-256.
| Crossref | Google Scholar | PubMed |

Werner RN, Gaskins M, Nast A, et al. Correction: Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection – a meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLoS ONE 2019; 14(12): e0226209.
| Crossref | Google Scholar | PubMed |

Freeborn K, Portillo CJ. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. J Clin Nurs 2018; 27(17–18): 3254-3265.
| Crossref | Google Scholar | PubMed |

Powell VE, Gibas KM, DuBow J, et al. Update on HIV preexposure prophylaxis: effectiveness, drug resistance, and risk compensation. Curr Infect Dis Rep 2019; 21(8): 28.
| Crossref | Google Scholar | PubMed |

Sarno EL, Macapagal K, Newcomb ME. “The main concern is HIV, everything else is fixable”: indifference toward sexually transmitted infections in the era of biomedical HIV prevention. AIDS Behav 2021; 25(8): 2657-2660.
| Crossref | Google Scholar | PubMed |

10  Klasko-Foster L, Wilson K, Bleasdale J, et al. “Shades of risk”: understanding current PrEP users’ sexually transmitted infection perceptions. AIDS Care 2022; 34(3): 353-358.
| Crossref | Google Scholar | PubMed |

11  Nath R, Grennan T, Parry R, et al. Knowledge and attitudes of syphilis and syphilis pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: a qualitative study. BMJ Open 2019; 9(11): e031239.
| Crossref | Google Scholar | PubMed |

12  Rotsaert A, Nöstlinger C, Van Landeghem E, et al. Pre-exposure prophylaxis users’ attitudes about sexually transmitted infections and its influence on condom use: a mixed-method study in Belgium. AIDS Patient Care STDS 2022; 36(12): 483-492.
| Crossref | Google Scholar | PubMed |

13  Freddie. PrEP Clinic in British Columbia. 2024. Available at https://www.gofreddie.com/british-columbia [accessed 6 November 2023]

14  Freddie. PrEP Clinic in Ontario. 2024. Available at https://www.gofreddie.com/ontario [accessed 6 November 2023]

15  Grace D, Gaspar M, Wells A, et al. Injectable pre-exposure prophylaxis for HIV prevention: perspectives on the benefits and barriers from gay, bisexual, and queer men and health system stakeholders in Ontario, Canada. AIDS Patient Care STDs 2023; 37(6): 306-315.
| Crossref | Google Scholar | PubMed |

16  Gaspar M, Grey C, Wells A, et al. Public health morality, sex, and COVID-19: sexual minority men’s HIV pre-exposure prophylaxis (PrEP) decision-making during Ontario’s first COVID-19 lockdown. Crit Public Health 2022; 32(1): 116-126.
| Crossref | Google Scholar |

17  Grace D, Daroya E, Gaspar M, et al. Gay, bisexual, and queer men’s confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over time. Sex Health 2023; 20(3): 223-231.
| Crossref | Google Scholar | PubMed |

18  Daroya E, Wells A, Gaspar M, et al. Navigating patterns of oral PrEP use: a qualitative longitudinal study of gay, bisexual, and queer men’s dynamic practices of pausing, on-demand, and stopping PrEP in Canada. SSM - Qualit Res Health 2024; 5: 100446.
| Crossref | Google Scholar |

19  Canadian Paediatric Society. Medical decision-making in paediatrics: infancy to adolescence. Canadian Paediatric Society. 2018. Available at https://cps.ca/documents/position/medical-decision-making-in-paediatrics-infancy-to-adolescence [accessed 6 December 2023]

20  Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77-101.
| Crossref | Google Scholar |

21  Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health 2019; 11(4): 589-597.
| Crossref | Google Scholar |

22  Grossoehme D, Lipstein E. Analyzing longitudinal qualitative data: the application of trajectory and recurrent cross-sectional approaches. BMC Res Notes 2016; 9(1): 136.
| Crossref | Google Scholar |

23  Grace D, Chown SA, Kwag M, et al. Becoming “Undetectable”: longitudinal narratives of gay men’s sex lives after a recent HIV diagnosis. AIDS Edu Prev 2015; 27(4): 333-349.
| Crossref | Google Scholar | PubMed |

24  Health Initiative for Men. Doxycycline PEP and PrEP. Health Initiative for Men (HIM). 2022. Available at https://checkhimout.ca/doxycycline/ [accessed 25 May 2023]

25  Earnshaw V, Kalichman SC. Stigma experienced by people living with HIV/AIDS. In: Liamputtong P, editor. Stigma, discrimination and living with HIV/AIDS: a cross-cultural perspective. Dordrecht: Springer Science + Business Media; 2013. pp. 23–38. 10.1007/978-94-007-6324-1

26  Kolstee J, Prestage G, Bavinton B, et al. Trust, familiarity, optimism, and pleasure: Australian gay men accounting for inconsistent HIV prevention practices in the prep era. Arch Sex Behav 2022; 51(5): 2563-2570.
| Crossref | Google Scholar | PubMed |

27  Holt M, Bernard D, Race K, et al. Gay men’s perceptions of sexually transmissible infections and their experiences of diagnosis: ‘part of the way of life’ to feeling ‘dirty and ashamed’. Sex Health 2010; 7(4): 411-416.
| Crossref | Google Scholar | PubMed |

28  Duncan B, Hart G, Scoular A, et al. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001; 322(7280): 195-199.
| Crossref | Google Scholar | PubMed |

29  Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am J Public Health 2015; 105(10): 1960-1964.
| Crossref | Google Scholar | PubMed |

30  Martinez-Lacabe A. The PrEP response in England: enabling collective action through public health and PrEP commodity activism. Crit Public Health 2021; 31(2): 226-234.
| Crossref | Google Scholar |